These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 31389218

  • 1. Central Serous Chorioretinopathy Following Intravitreal Dexamethasone Implant.
    Noh GM, Nam KY, Lee SU, Lee SJ.
    Korean J Ophthalmol; 2019 Aug; 33(4):392-394. PubMed ID: 31389218
    [No Abstract] [Full Text] [Related]

  • 2. Central Serous Chorioretinopathy.
    Daruich A, Matet A, Behar-Cohen F.
    Dev Ophthalmol; 2017 Aug; 58():27-38. PubMed ID: 28351043
    [Abstract] [Full Text] [Related]

  • 3. Bilateral central serous chorioretinopathy with retinal pigment epithelium tears following epidural steroid injection.
    Lee SB, Kim JY, Kim WJ, Cho CB, Iwase T, Jo YJ.
    Indian J Ophthalmol; 2013 Sep; 61(9):514-5. PubMed ID: 24104712
    [Abstract] [Full Text] [Related]

  • 4. Masqueraders of central serous chorioretinopathy.
    Sahoo NK, Singh SR, Rajendran A, Shukla D, Chhablani J.
    Surv Ophthalmol; 2019 Sep; 64(1):30-44. PubMed ID: 30243734
    [Abstract] [Full Text] [Related]

  • 5. A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema.
    Callanan DG, Loewenstein A, Patel SS, Massin P, Corcóstegui B, Li XY, Jiao J, Hashad Y, Whitcup SM.
    Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):463-473. PubMed ID: 27632215
    [Abstract] [Full Text] [Related]

  • 6. Recurrent Central Serous Chorioretinopathy with Dexamethasone Eye Drop used Nasally for Rhinitis.
    Prakash G, Shephali J, Tirupati N, Ji PD.
    Middle East Afr J Ophthalmol; 2013 Mar; 20(4):363-5. PubMed ID: 24339692
    [Abstract] [Full Text] [Related]

  • 7. Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy.
    Gawęcki M, Jaszczuk-Maciejewska A, Jurska-Jaśko A, Kneba M, Grzybowski A.
    BMC Ophthalmol; 2019 Jul 25; 19(1):160. PubMed ID: 31345183
    [Abstract] [Full Text] [Related]

  • 8. TWELVE-MONTH EFFICACY OF INTRAVITREAL BEVACIZUMAB INJECTION FOR CHRONIC, ATYPICAL, OR RECURRENT CENTRAL SEROUS CHORIORETINOPATHY.
    Chung YR, Kim JW, Song JH, Park A, Kim MH.
    Retina; 2019 Jan 25; 39(1):134-142. PubMed ID: 29077604
    [Abstract] [Full Text] [Related]

  • 9. Morphological and functional changes in recalcitrant diabetic macular oedema after intravitreal dexamethasone implant.
    Iacono P, Parodi MB, Scaramuzzi M, Bandello F.
    Br J Ophthalmol; 2017 Jun 25; 101(6):791-795. PubMed ID: 27625164
    [Abstract] [Full Text] [Related]

  • 10. Extramacular Retinal Hole Following Intravitreal Dexamethasone Implant: Case Report.
    Ekinci C, Kayıran A, Özdemir H.
    Turk J Ophthalmol; 2019 Jun 27; 49(3):175-177. PubMed ID: 31245982
    [Abstract] [Full Text] [Related]

  • 11. Quantification of fluid resorption from diabetic macular oedema with foveal serous detachment after dexamethasone intravitreal implant (Ozurdex® ) in a pregnant diabetic.
    Hodzic-Hadzibegovic D, Ba-Ali S, Valerius M, Lund-Andersen H.
    Acta Ophthalmol; 2017 May 27; 95(3):324-325. PubMed ID: 27778454
    [Abstract] [Full Text] [Related]

  • 12. Early Retinal and Choroidal Coat Thickness Changes after Intravitreal Dexamethasone Implant Injection for Diabetic Macular Edema.
    Horozoğlu F, Sever Ö.
    Balkan Med J; 2018 Sep 21; 35(5):384-387. PubMed ID: 29866639
    [Abstract] [Full Text] [Related]

  • 13. Leopard-Spot Subretinal Deposits in Central Serous Chorioretinopathy.
    Marchese A, Miserocchi E, Modorati G, Querques G, Bandello F.
    Retina; 2018 Jul 21; 38(7):e53-e54. PubMed ID: 29697592
    [No Abstract] [Full Text] [Related]

  • 14. Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (CSC) diagnosed by swept source optical coherence tomography angiography (SS OCTA).
    Sulzbacher F, Schütze C, Burgmüller M, Vécsei-Marlovits PV, Weingessel B.
    Graefes Arch Clin Exp Ophthalmol; 2019 Aug 21; 257(8):1581-1590. PubMed ID: 31037488
    [Abstract] [Full Text] [Related]

  • 15. Repeated Dexamethasone Intravitreal Implant for the Treatment of Diabetic Macular Oedema Unresponsive to Anti-VEGF Therapy: Outcome and Predictive SD-OCT Features.
    Hatz K, Ebneter A, Tuerksever C, Pruente C, Zinkernagel M.
    Ophthalmologica; 2018 Aug 21; 239(4):205-214. PubMed ID: 29402873
    [Abstract] [Full Text] [Related]

  • 16. Exacerbation of central serous chorioretinopathy following PASCAL photocoagulation.
    Yang HS, Park SH.
    Can J Ophthalmol; 2013 Jun 21; 48(3):e42-3. PubMed ID: 23769790
    [No Abstract] [Full Text] [Related]

  • 17. Intravitreal Bevacizumab and Ranibizumab in the Treatment of Acute Central Serous Chorioretihopathy: A Single Center Retrospective Study.
    Tekin K, Sekeroglu MA, Cankaya AB, Teke MY, Doguizi S, Yilmazbas P.
    Semin Ophthalmol; 2018 Jun 21; 33(2):265-270. PubMed ID: 27841949
    [Abstract] [Full Text] [Related]

  • 18. Effect of intravitreal dexamethasone implant on retinal and choroidal thickness in refractory diabetic macular oedema after multiple anti-VEGF injections.
    Kim M, Cho YJ, Lee CH, Lee SC.
    Eye (Lond); 2016 May 21; 30(5):718-25. PubMed ID: 26939558
    [Abstract] [Full Text] [Related]

  • 19. Central Serous Chorioretinopathy Associated With Fingolimod Treatment.
    Khimani KS, Foroozan R.
    J Neuroophthalmol; 2018 Sep 21; 38(3):337-338. PubMed ID: 29140860
    [No Abstract] [Full Text] [Related]

  • 20. Dexamethasone for unresponsive diabetic macular oedema: optical coherence tomography biomarkers.
    Bonfiglio V, Reibaldi M, Pizzo A, Russo A, Macchi I, Faro G, Avitabile T, Longo A.
    Acta Ophthalmol; 2019 Jun 21; 97(4):e540-e544. PubMed ID: 30318792
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.